Welcome to our dedicated page for 4Front Ventures news (Ticker: FFNTF), a resource for investors and traders seeking the latest updates and insights on 4Front Ventures stock.
4Front Ventures Corp. reports developments as a vertically integrated, multi-state cannabis operator with cultivation, production, distribution and retail activities in Illinois and Massachusetts and facilities in Washington. Its updates cover cannabis brands and products distributed through fully owned Mission dispensaries and other retail outlets, along with facility activity such as the Matteson operation in Illinois and wholesale performance in Massachusetts.
Recent company news also centers on corporate-status and disclosure matters, including delayed annual filings, a management cease trade order application, a failure-to-file cease trade order, board changes, equity grants, Canadian bankruptcy proceedings, and voluntary receivership proceedings involving its U.S. subsidiaries. Financial releases discuss revenue trends, adjusted operating metrics, market demand, cultivation testing, manufacturing capacity and retail execution across its core cannabis markets.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) reported a 6% year-over-year increase in systemwide pro forma revenue, totaling $139.4 million for FY 2022 and $35.6 million for Q4 2022. The company achieved GAAP revenue growth of 13% to $118.5 million for FY 2022. However, Adjusted EBITDA decreased to $27.7 million from $33.9 million in FY 2021. As of December 31, 2022, cash reserves reached $15.2 million, and the company announced positive operational cash flow as of March 2023. 4Front has acquired a third retail license in Illinois, bolstering its strategy in the state.